Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current therapeutic algorithms for type 2 diabetes.

D Le Roith1

  • 1Clinical Endocrinology Branch, National Institutes of Health, Bethesda, Maryland, USA.

Clinical Cornerstone
|February 13, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The proposed terminology 'A(1c)-derived average glucose' is inherently imprecise and should not be adopted.

Diabetologia·2008
Same author

Pathogenesis of diabetes: our current understanding.

Clinical cornerstone·2002
Same author

Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes.

Genes & development·2001
Same author

Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects.

Molecular pathology : MP·2001
Same author

The role of the insulin-like growth factors in cancer.

The Israel Medical Association journal : IMAJ·2001
Same author

Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity.

Diabetes·2001
Same journal

Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical options.

Clinical cornerstone·2009
Same journal

Guiding clinical decisions on abdominal obesity and cardiometabolic risk.

Clinical cornerstone·2009
Same journal

Overweight and obesity: the pathogenesis of cardiometabolic risk.

Clinical cornerstone·2009
Same journal

Obesity as a disease state: a new paradigm for diagnosis and treatment.

Clinical cornerstone·2009
Same journal

Pathogenesis of cardiometabolic risk as it relates to overweight and obesity. Introduction.

Clinical cornerstone·2009
Same journal

Should clinicians routinely determine rhinitis subtype on initial diagnosis and evaluation? A debate among experts.

Clinical cornerstone·2009
See all related articles

Managing type 2 diabetes involves achieving normal hemoglobin A1c, lipids, and blood pressure to reduce complications. This article reviews standard and newer treatment approaches for optimal metabolic control.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Diabetes Management

Background:

  • Type 2 diabetes is a complex condition with varied patient presentations.
  • Common management objectives include achieving tight metabolic control to prevent long-term complications.

Purpose of the Study:

  • To outline the established and emerging therapeutic strategies for type 2 diabetes management.
  • To emphasize the importance of normalizing hemoglobin A1c, lipid profiles, and blood pressure.

Main Methods:

  • Review of current pharmacological and non-pharmacological treatment regimens.
  • Discussion of novel therapeutic agents and approaches for glycemic and cardiovascular risk reduction.

Main Results:

  • Standard treatments aim to improve glycemic control and cardiovascular risk factors.

Related Experiment Videos

  • Emerging therapies offer enhanced options for achieving treatment goals.

    • Conclusions:

    • Comprehensive management of type 2 diabetes requires addressing glycemic control, lipids, and blood pressure.
    • Continuous evaluation and integration of new therapeutic strategies are crucial for improving patient outcomes.